POSA67 Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Versus Dual Therapies in Moderate-to-Very Severe COPD: United Kingdom Analysis Using the ETHOS Study
Abstract
Authors
E de Nigris C Treharne N Brighton U Holmgren M Jenkins A Walker J Haughney